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The aqueous extract of Psidium guajava budding leaves (PE) bears an extremely high content of polyphenolic and isoﬂavonoids.
Whether it could be used as an anti-tumor chemopreventive in view of anti-angiogenesis and anti-migration, we performed the
assaymethodsincludingtheMTTassaytoexaminethecellviability;theELISAassaytotesttheexpressionsofVEGF,IL-6andIL-8;
the western blot analysis to detect TIMP-2; the gelatinolytic zymography to follow the expression of MMPs; the wound scratch
assay to examine the migration capability; and the chicken chorioallantoic membrane assay to detect the suppressive angiogenesis.
Results indicated that the IC50 of PE for DU145 cells was ∼0.57mgml−1. In addition, PE eﬀectively inhibited the expressions of
VEGF, IL-6 and IL-8 cytokines, and MMP-2 and MMP-9, and simultaneously activated TIMP-2 and suppressed the cell migration
and the angiogenesis. Conclusively, PE potentially possesses a strong anti-DU145 eﬀect. Thus, clinically it owns the potential to be
used as an eﬀective adjuvant anti-cancer chemopreventive.
1.Introduction
Angiogenesis is a highly regulated process essential to
reproductionandwoundhealing.Uncontrolledangiogenesis
could induce a number of diseases, including arthritis,
diabetes-related blindness, psoriasis, tumor growth and
metastasis. As well known, hypoxia is closely related with
many common features of solid tumors [1] and is the most
potent stimuli for expression of the vascular endothelial
growth factor (VEGF) mediated primarily by the hypoxia
inducible factor-1 (HIF-1), a master regulator of angio-
genesis in hypoxia [2]. Pharmacologically, anti-angiogenic
compounds are useful in treating diseases having uncon-
trolled angiogenesis, in contrast, pro-angiogenic compounds
are beneﬁcial to wound healing in minimizing tissue dam-
ages following ischemia injury. Literally, the angiogenesis
induction during tumor growth and metastasis has become
one of the focci in cancer research. Many natural products
having multiple biological mechanisms are cumulatively
considered to have chemopreventive eﬀects [3, 4]. Accord-
ingly,theanti-angiogenicityhasbecomeanalternativemech-
anism for identiﬁcation of chemopreventive agents. Based
on this, a diversity of assay methods has been developed
to investigate both the pro- and anti-angiogenic eﬀects of2 Evidence-Based Complementary and Alternative Medicine
potential new drugs [5]. Literature elsewhere indicated that
the activity of matrix metalloproteinases may be related with
angiogenesis. However, only the MMP-13 (chMMP-13) in
chicken embryo has been identiﬁed to be closely associated
with its vascularization. Biochemically, chicken MMP-13
(chMMP-13) is the only enzyme whose induction and
expression coincided with the angiogenesis and blood vessel
formation [6]. In addition, many smaller peptides have been
shown to bear more potent anti-angiogenic and inhibitory
activities on the endothelial cell proliferation. Usually, these
peptides are administered as one of the pharmaceutical
compositions in the prevention and treatment of undesired
angiogenesis, especially for the prevention of primary tumor
growthand theinhibition of tumor metastasis(United States
Patent 7317003).
Psidium guajava L. belongs to the family of Myrtaceae-
MyrtleandthegenusofPsidiumguajava L.—guava[7].Psid-
ium guajava L. is an important tropical fruit widely grown
in Taiwan, Hawaii, Thailand, Philippines and Malaysia. All
parts of which including the fruits, leaves and barks have
been traditionally used as the folkloric herbal medicines
and exhibit many therapeutic uses including amebicide,
analgesic, vermifuge, anti-malarial, anti-bacterial, colic-
relief, anti-spasmodic, astringent, anti-ulcerous, gastroto-
tonic cough suppressant, hypotensive, anti-inﬂammatory,
diarrhea, some psychic diseases and hyperglycemia. Other
documented medicinal uses are antianxiety, anti-spasmodic,
anti-convulsant, antiseptic, blood cleanser, digestive and
menstrual stimulants, infantile rotavirus enteritis, antiseptic,
anti-oxidant, cardiodepressant, cardiotonic, central nervous
system depressant, febrifuge and a topical remedy for ear
and eye infections [7]. The aqueous extract of P. guajava
L. (guava) budding leaf extract (PE) was reported to
possess anti-oxidative, anti-glycative, anti-angiogenic eﬀects
[8], and anti-carcinogenic bioactivities [9], eﬀects having
been attributed to its extraordinary free radical scavenging
and anti-oxidative capabilities. The high polyphenolic and
ﬂavonoid contents in PE are relevantly associated with its
potent anti-glycative activity [10], implicating its beneﬁcial
eﬀect for treatment of many cardiovascular and neural
degenerative diseases [7]. More recently, we reported that PE
contained signiﬁcant amount of β-sitosterol glucoside and
brahmic acid [7], apparently contributing to the lowering of
plasma glucose levels in both non-diabetic and diabetic rats
[7]. In this study, we try to elucidate the bioactivities of PE as
anti-angiogenesis or anti-metastasis of prostate cancer using
DU145 cells.
2.MaterialsandMethods
2.1. Reagent, Chemicals and Antibodies. Dulbecco’s Modiﬁed
Eagle Medium (DMEM), penicillin, streptomycin, fetal
bovine serum (FBS), trypsin-EDTA and phosphate buﬀered
saline (PBS) were purchased from Gibco (Langley, OK,
USA). Acrylamide and the protein assay kit were obtained
from Bio-Rad (Hercules, CA, USA). Polyclonal anti-MMP-2
and anti-MMP-9 were purchased from Sigma Chemicals (St
Louis, MO, USA). TIMP-2 antibodies were obtained from
Abcam (Taipei, Taiwan). β-Actin antibody was obtained
fromChemicon(USA).Allotherchemicalsusedinthisstudy
were purchased from authentic sources and of highest grade
and purity.
2.2. Preparation of Aqueous Extract of PE. PE was prepared
according to the method previously described by Hsieh et al.
[10].
2.3. Measurement of PE Components
2.3.1.Water-SolublePolysaccharideandSolubleSmallMolecu-
lar Polyphenolics. The water-soluble polysaccharide fraction
was isolated by similar method previously reported [11]
with some modiﬁcations. Brieﬂy, to 5.00g of PE, 250ml of
deionized water was added. The mixture was boiled for 1h
and centrifuged at 3000r.p.m. and for 30 min the sediment
(2.31g) was dried under nitrogen blowing to yield a residue
of 0.24g (SDI: recovery 4.80%). The supernatant (SI Super:
197.2ml) was added with ethanol (95% v/v, 592ml) to
adjust the ethanol content to a ﬁnal value of 71.25%. The
mixture was agitated for 30 min and centrifuged at 10 000g
for 30 min. The sediment (SDII: wet weight 14.36g) was
lyophilized to give the water soluble polysaccharide fraction
(SDIII Pws: dried weight 1.14g, recovery 22.80%). The
supernatant containing small molecular polyphenolics (SII
Super, 752.04ml) was evaporated under reduced pressure
and then decanted out of the evaporation ﬂask (the decant,
the original concentrate). The empty ﬂask was rinsed
with the deionized water (dw, 100ml). The washings were
combined by decanting and subjected to lyophilization. The
yield was 3.36g based on the desiccated PE. This product in
factrepresentedthesmallmolecularpolyphenolicfractionof
PE (Φsm: 3.36g, recovery 67.2%).
2.3.2. The Polysaccharides. To 0.5mL of ADP, 0.5mL of
phenol color reagent (5%) was added. The mixture was
vigorously agitated to facilitate a homogeneous solution.
Sulfuric acid (2.5ml) was rapidly dropped in. The mixture
was agitated thoroughly to facilitate the color reaction
(orange color). Optical density was measured at 490nm.
2.3.3. Total Polyphenolics. The desiccated herbal aqueous
extract (5mg) was dissolved in an acidic mixed solvent
of methanol/water (60:40, 0.3% HCl). The following pro-
cedures were conducted according to Hsieh et al. [10].
The amount of polyphenolics present in the extracts was
expressed as the gallic acid equivalents per gram sample,
GAE/g.
2.3.4. Total Flavonoids. The method described by Hsieh et al.
[10] was followed. Brieﬂy, to 1mL of the aqueous solution
of herbal extract (1mgmL−1), 1.25mL of deionized water
was added and mixed thoroughly with 75μLo fN a N O 2
(5%). The remaining procedures were conducted in the
same manner as described. The absorbance was measured
at 510nm and calculated against the calibration curve
established using catechin as the reference standard and
expressed as the catechin equivalents per gram sample, CE/g.Evidence-Based Complementary and Alternative Medicine 3
2.4. Cell Line and Cell Culture. Human prostate carcinoma
DU-145 cells were purchased from the Culture Collection
and Research Center (CCRC) of the Food Industry Research
and Development Institute (FIRDI) (Hsinchu, Taiwan).
DU-145 cells were cultured in RPMI 1640 media with
5% FBS and 1% penicillin-streptomycin cocktail (Cellgro,
Mediatech, Inc., Herndon, VA, USA) at 37◦C in a humidiﬁed
atmosphere containing 5% CO2.
2.5. Cell Viability Assay. M T Ta s s a yw a sp e r f o r m e dm a i n l y
by following the method described by Mosmann [12], yet
modiﬁed by the manufacturer (Bio-Tek Instruments, VT,
USA).
2.6. ELISA Assay for VEGF, IL-6 and IL-8. DU145 cells
were seeded onto 24-well plates at a cell count of 2 × 104
cells/well in a regular culture medium and incubated at
37◦C for 48h in the absence and the presence of PE at
concentrations as indicated. The conditioned medium was
collected and immediately frozen to −20◦C for further use.
Otherwise, these culture media were assayed fresh with a
sandwich ELISA for VEGF, IL-6 and IL-8 according to the
manufacturer’s protocol (RayBiotech, Inc., Norcross, GA,
USA).
2.7. Western Blotting Analysis. After incubated in the pres-
ence and the absence of PE, the DU145 cells were rinsed and
lyzed following the standard procedure of cell preparation
for Western Blotting [9]. The total protein extraction and
quantiﬁcation were performed as directed (BCA protein
assay, Pierce, USA). The blotted membranes were incu-
bated with TIMP-2 antibody (Abcam, Taipei, Taiwan). The
immunoblotting signals were detected by chemilumines-
cence method as instructed (The ECL Western Blotting
System, Amersham Pharmacia Biotech). The amount of
proteins in gel slabs was quantiﬁed using a densitometer
(ImageProPlus5.0MedicaCybernetics).β-Actinwasusedas
the internal control and treated with the same protocol [9].
2.8. Gelatinolytic Zymography. Gelatinolytic zymography
was used to detect the expression of MMPs in supernatant
media in presence or absence of PE as described by Leber
and Balkwill [13] with slight modiﬁcation. Brieﬂy, the
collectedmedia(10μl)aftertreatmentwereloadedonto10%
sodium dodecyl sulfate (SDS)-polyacrylamide gel (SDS–
PAGE) copolymerized with 0.1% gelatin and subjected to
electrophoresis at 100 V for 1.5h. In order to remove SDS,
the gel was rinsed twice for 30 min, each with 2.5% Triton
X-100 solution, then rinsed with incubation buﬀer (0.05M
Tris-HCl buﬀer, pH 8.0 containing 5 mM CaCl2 plus 5
mM ZnCl2) and incubated at 37◦C overnight. The gel was
stained with PhastGel Blue R at ambient temperature for 2h.
Gelatinases in media were detected as unstained degraded
zones of gelatin on the gel and were quantiﬁed using a
densitometer (ImagePro Plus 5.0 Medica Cybernetics).
2.9. Wound Scratch Assay. DU-145 cells (3 × 104 ml−1)w e r e
seeded into 6-well tissue culture dishes and cultured in
medium containing 10% FBS to conﬂuent cell monolayers,
whichwerethencarefullywoundedusingsterileP200pipette
tips and removed any cell debris with PBS [14]. The cells
were treated with PE at various concentration levels as
indicatedfor24handitsmigrationwasphotographedunder
a phase contrast microscope. The cell migration ability can
be expressed by the relative migration capability originally
derived Liu et al. [15] with slight modiﬁcation in this article
Rm =
St
Su
,( 1 )
where Rm is the relative migration capability (dimension-
less). St is the migration distance of drug-treated cells (mm),
and Su is the migration distance of untreated cells (mm).
Similar experiments were repeated in triplicates.
2.10. Chicken Chorioallantoic Membrane Assay. Fertilized
chick eggs are incubated at 37◦C and a speciﬁc humidity of
60% for 3 days (Incubators and More, Adelaide, Australia).
A rectangular window (1 × 1.5cm) was made in the eggshell
and the eggs were replaced in the incubator without rotation
until day 9 when ﬁlter paper disks saturated with PE (5mg
200μl per egg) were placed on the chorioallantoic mem-
brane. The normal unmanipulated chorioallantoic mem-
branewasusedascontrols.Theincubationwascontinuedfor
2daysfurther.Thedevelopingvasculaturewasobservedonce
daily under a stereomicroscope. The extent of agiogenesis
(the neovascular zones) was evaluated on the chorioallantoic
membranephotographedat×5magniﬁcationbyadissecting
microscope (SZ-CTV Olympus Optical Co, Ltd, Tokyo,
Japan) attached with a digital camera (Panasonic GP KR222,
Panasonic, Osaka, Japan).
2.11. Statistics. T h ev a l u e sw e r ee x p r e s s e da sm e a n s± SE.
The signiﬁcance between the control and treated groups was
determined by Student’s t-test.
3. Results
3.1. Tumor Cell Viability Was Suppressed in a Dose-Responsive
Manner. After incubation for 48h PE suppressed the cell
viability in a dose-responsive manner, from which the level
of IC50 was estimated to be ∼0.57mgml−1 (Figure 1).
3.2. Expression of VEGF Was Eﬀectively Attenuated. The
VEGFexpressionwaseﬀectivelysuppressedbyPEat0.25,0.5
and 1.0mgml−1, the percent suppression attained 36.6, 41.2
and 76.91%, respectively (Figure 2) when compared with the
control (1240pgml−1) taken as 100%.
3.3. Anti-Angiogenesis Was Found by the Chicken Chorioal-
lantoic Membrane Assay. After the fertilized chicken egg
received 200μlP Ep e re g g( Figure 3) (concentration of PE,
25mgml−1), the angiogenesis was eﬀectively suppressed (b)
compared to the control (the untreated (a)).
3.4.ExpressionsofIL-6andIL-8WereProminentlySuppressed.
The expression of IL-6 also was apparently inhibited by PE4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Eﬀe c to fP Eo nt h eD U 1 4 5c e l lv i a b i l i t y .T h eD U 1 4 5
cells were exposed to PE at concentrations of 0.1, 0.25, 0.5 and
1.0mgml−1, respectively for 24 and 48h. The viability (%) was
determined by MTT assay. The vehicle-treated cells were used as
the control (100%). Data were expressed in mean ± SD of the
triplicates. ∗P < .05 to compare the cell viability between the treated
and the untreated.
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Figure 2: Eﬀect of PE on VEGF expression in DU145 cells. DU145
was incubated at 37◦C for 48h in the absence or the presence of PE
(0.25, 0.5, 1.0mgml−1). Data were expressed in mean ± SD of the
triplicates. ∗P < .01 to compare the VEGF expression between the
treated and the untreated.
at concentrations 0.25, 0.5 and 1.0mgml−1,r e s p e c t i v e l y .
The percent inhibitions obtained were 34.4, 86.0 and 98.8%,
respectively (Figure 4(a)). Similarly, PE aﬀected the expres-
sion of IL-8 as for IL-6 in DU145 cells. At indicated exper-
imental concentrations, the percent inhibition was 51.6,
87.2 and 98.0%, respectively, at 0.25, 0.5 and 1.0mgml−1
(Figure 4(b)).
3.5. PE Downregulated MMP-2, MMP-9 and Upregulated
TIMP-2 in DU145 Cells. PE simultaneously downregulated
both the matrix metalloproteinases, MMP-2 and MMP-9, in
adose-responsivemanner.TheMMP-9wasmoresusceptible
to PE treatment than MMP-2. As can be seen, the complete
inhibition of MMP-2 required a dose of PE 1.0mgml−1,
whereas for MMP-9 only required a dosage of 0.25mgml−1
(Figure 5(a)). As for TIMP-2, an increased activity to 1.85-
and 1.99-fold was indicated in the presence of 0.25 and
1.0mgml−1 of PE, respectively (Figure 5(b)).
3.6. Tumor Cell Migration Was Eﬀe c t i v e l yI n h i b i t e db yP E .
PE at concentrations as indicated eﬀectively suppressed
the cell migration of DU145 cells. The original wound
scratch was as wide as shown in the upper left top picture
indicated as 0 day. To low the PE dosages, the wounded
area on the plate was completely healed (Figure 6(a),a t
PE 0.1mgml−1). When dosages of PE were increased, the
cells became unable to across the wounded area of similar
widths and failed to heal over the entire area. Instead,
a gap was left behind as shown in B to D in a dose-
responsive manner when incubated with PE 0.25, 0.5 and
1.0mgml−1,r e s p e c t i v e l y( Figure 6(a)). Quantitatively, the
migratorycapabilitywascorrespondinglysuppressedto77.7,
74.0and30.9%,respectively(Figure 6(b)).Animplication is
in the suppression of migratory capability of the DU145 cells
by PE.
4. Discussion
Often, expression of VEGF has been considered to be
required for tumor cell proliferation and growth [1]. The
binding of VEGF to VEGF receptor-2 (VEGFR-2) located
on the endothelial cells brought forth the phosphorylation
on VEGFR-2, which in turn activated the signaling pathways
of Akt/PKB, p44/42MAP(ERK1/2) and p38MAPK [16–18].
As noted, the pathways Akt/PKB and ERK(1/2) are closely
associated with the cell growth, proliferation and survival.
In contrast, P38MAPK is related with the cell migration
capability. Recently, Thejass and Kuttan [19] demonstrated
that VEGF induced the migration and tubular formation
in vascular endothelial cells. Similar phenomenon had also
been conﬁrmed in the prostate cancer LNCaP cells, the most
popular type of prostate cancer.
Usually,IL-6isexpressedintheprostatestromaandbasal
epithelial cells. Frequently, it is highly expressed in some
typesofprostatecancers,whichinturnparticipatesininduc-
ing angiogenesis in many cancer tissues [20]. Clinical data
had shown highly expressed IL-6 and the prostate-speciﬁc
antigen(PSA)inhormone-independentpatients[20].Under
such a circumstance, IL-6 has been considered to act as
the signaling messenger in many hormone refractory cancer
cells,whichinrealityisassociatedwithsignaling pathwaynet
including the mitogen-activated protein kinase (MAPK), the
signal transducer and activators of transcription-3 (STAT-3),
etc. As often cited, MAPK is related with cell growth and
diﬀerentiation, while STAT-3 is able to activate the androgen
receptor (AR) in the prostate cells through the expression
of some neuropeptides. Obviously, to suppress the secretion
of IL-6 will concomitantly inhibit the activation of AR. As
a consequence, the progression of prostate cancer can be
eﬀectively retarded [21].Evidence-Based Complementary and Alternative Medicine 5
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Figure 3: Eﬀect of PE on angiogenesis. Chicken chorioallantoic membrane assay was conducted with addition of PE (200μlp e re g go f
as o l u t i o no fP E2 5m gm l −1) in a 9-day-old chicken embryo. The extent of neovascularization was examined 48h after treatment in the
absence (a) and the presence (b) of PE.
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Figure 4: Eﬀect of PE on expressions of IL-6 and IL-8 in DU145 cells. DU145 cells were incubated at 37◦C for 48h in the absence and the
presence of PE at concentrations of 0.25, 0.5, 1.0mgml−1, respectively. Both IL-6 (a) and IL-8 (b) were eﬀectively suppressed as shown. Data
were expressed in mean ± SD of the triplicates. ∗P < .01 to compare the expressions of IL-6 and IL-8 between the treated and the untreated.
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Figure5:EﬀectofPEonexpressionofMMP-2andMMP-9inDU145cells.DU145cells(1 ×107 cells)weretreatedwithPEatconcentrations
(from A to E) 0, 0.1, 0.25, 0.5 and 1.0mgml−1 respective (A), and for TIMP2 assay: DU145 cells (1 × 107 cells) were seeded onto a 10cm
dish in the absence or the presence of PE at concentrations of 0.25 and 1.0mgml−1, respectively. All cultures were incubated at 37◦Cf o r
48h. The gelatin zymography showing the clear zones against the background reveals a dose responsive expression of both the matrix
metalloproteinases MMP-2 and MMP-9 (a). For TIMP-2, an increased activity to 1.85- and 1.99-fold was indicated in the presence of 0.25
and 1.0mgml−1 of PE, respectively (b).6 Evidence-Based Complementary and Alternative Medicine
ABCD 0day
(a)
0
20
40
60
80
100
120
0 0.25 0.5 1
PE (mg/mL)
M
i
g
r
a
t
i
o
n
a
r
e
a
(
%
)
∗
∗
∗
(b)
Figure 6: Eﬀect of PE on the migration of DU145 cells. U145 cells (3 × 105 cells/well) were seeded onto a 6-well plate. On 80% conﬂuence,
wound scratches were made with sterile P200 pipette tips. The plates were washed twice with PBS to remove detached cells. The cells were
treated with PE at concentrations of A. 0, B. 0.25, C. 0.5 and D. 1mgml−1, respectively (a). After incubated for 24h, the migrated distances
were evaluated. Data were expressed in mean ± SD from triplicate experiments (b). ∗P < .05 compared with blank.
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Figure 7: Action mechanism of the aqueous extract of PE on the
DU145 cell line. The cell viability was prominently suppressed by
PE. The angiogenesis was inhibited by PE through the downregula-
tionofVEGF,IL-6andIL-8.Thecellmigrationwasfoundinhibited
through downregulation of MMP-2, MMP-9 and TIMP-2.
As a contrast, IL-8 usually is expressed in the normal
prostate epithelium and DU145 cells. Its expression is
closely related with the angiogenesis and the cell migration,
which otherwise is interlinked with the upregulation of
the extracellular-regulated kinase (ERK) [20]. In animal
model, Oppenheim and Fujiwarat [22] indicated that the
angiogenesis and cell growth were eﬀectively suppressed
when the IL-8 secretion was inhibited. As can be seen,
PE eﬃciently suppressed the expression of IL-6 and IL-8,
at dosage below 1.0mgml−1, implicating its future clinical
applicability. The matrix metalloproteinases (MMPs) are
frequentlyconcernedwiththetissuerepairingandindividual
development. Although they were only slightly expressed,
yet they were highly modulated. In tumor cells, they are
always signiﬁcantly expressed in the triggered cell migration.
MMPsactontheextracellularmatrix(ECM),resultinginthe
hydrolysis, degradation and separation of the intercellular
ECM. Consequently, MMPs are closely related with the
cancer migration and invasiveness. In addition, MMPs help
the vascularization by hydrolyzing the ECM in blood vessels.
Cell migration and angiogenesis are thus greatly enhanced
resulting from the improved permeability and inﬁltration
[22]. Among these both, the MMP-2 and MMP-9 contribute
much more to the cancer invasiveness and metastasis [23]. In
our experiment, PE downregulated the expression of MMP-
2 and MMP-9, and activated TIMP-2, revealing a double
strength anti-cancer eﬀect.
To summarize, the aqueous extract of PE leaves has
shown amazing anti-cancer eﬀects on the DU145 cells. The
entire mechanism involved the suppression of cell viability,
the reduced production of VEGF, the anti-angiogenic eﬀect,
the downregulation of IL-6 and IL-8, the inhibition on
MMP-2 and MMP-9, and ﬁnally the activation of TIMP. The
overall action mechanism of PE on DU-145 cells is shown in
Figure 7.
Recent progress and promotion in the use of comple-
mentary adjuvant medicines (CAM) indeed has inspired the
research interest and clinical trial of anti-cancer therapy.
T h e s er e p o r t sc a nb eo ft r e m e n d o u sv a l u ei nt h i sr e g a r d .
Recently, our laboratory has identiﬁed that PE contained
a tremendous polyphenolic compounds including gallicEvidence-Based Complementary and Alternative Medicine 7
acid, catechin, epicatechin, rutin, quercetin, naringenin and
kaempherol [8]. The total polyphenolic and isoﬂavonoid
contents reached 229 and 208mgg−1,r e s p e c t i v e l y[ 24]. Pre-
viously, the anti-angiogenic capability of epigallocatechin-
O-gallate (EGCG) and catechins has been demonstrated
by Cao et al. [25], and Kang [5] indicated that EGCG
inhibited angiogenesis in a dose-dependent fashion and
reached an overall inhibition of 30–63% on the VEGF/vs3
signaling pathway. Literature also demonstrated that DNA
fragmentation in DU145 cells was severely aﬀected in the
presence of 100–250μM of gallic acid, rutin, naringenin or
kaempherol after an incubation period of 48h [24]. Taken
together, the polyphenolic and isoﬂavonoid compounds
present in PE can contribute to its clinical uses.
5. Conclusion
TheaqueousextractofPEbearsanextremelyhighcontentof
polyphenolic and isoﬂavonoids. The IC50 of PE to suppress
the cell viability is ∼0.57mgml−1.P Ec a ne ﬀectively inhibit
the expression of VEGF, IL-6 and IL-8 cytokines, and MMP-
2 and MMP-9. In contrast, it activates TIMP and suppresses
the cell migration and the angiogenesis. We conclude that
PE potentially possesses a strong anti-prostate cancer eﬀect.
Results suggest that PE can be used as an eﬀective clinical
adjuvant anti-prostate cancer chemopreventive.
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